COMBINATION THERAPY OF INSULINOTROPIC PEPTIDE AND GLP-2, FOR PREVENTING OR TREATING SHORT BOWEL SYNDROME

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240299500A1
SERIAL NO

18269134

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a combination therapy using an insulinotropic peptide and GLP-2 for the prevention, improvement, or treatment of short bowel syndrome.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANMI PHARM CO LTDGYEONGGI DO SOUTH KOREA GYEONGGI-DO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHOI, Jae Hyuk Hwaseong-si, KR 60 328
HONG, Sung Hee Hwaseong-si,, KR 77 198
KWON, Hyun Joo Hwaseong-si, KR 3 0
LEE, Jin Bong Hwaseong-si, KR 6 0
LEE, Sang Hyun Hwaseong-si, KR 269 1466
YOO, Nyeong Sang Hwaseong-si,, KR 4 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation